# A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

> **NCT04975971** · — · COMPLETED · sponsor: **Nicole Fram M.D.** · enrollment: 25 (actual)

## Conditions studied

- Anterior Chamber Inflammation
- Ocular Pain
- Corneal Edema
- Corneal Defect
- Penetrating KeratoPlasty
- Nuclear Cataract
- Cortical Cataract
- Cataract Senile

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert

## Key facts

- **NCT ID:** NCT04975971
- **Lead sponsor:** Nicole Fram M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2021-05-19
- **Final completion:** 2021-05-19
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975971, "A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04975971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*